[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SK51595A3 - Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline active ingredients, and processs for producing the same - Google Patents

Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline active ingredients, and processs for producing the same Download PDF

Info

Publication number
SK51595A3
SK51595A3 SK515-95A SK51595A SK51595A3 SK 51595 A3 SK51595 A3 SK 51595A3 SK 51595 A SK51595 A SK 51595A SK 51595 A3 SK51595 A3 SK 51595A3
Authority
SK
Slovakia
Prior art keywords
matrix
layer
salt
patch
film
Prior art date
Application number
SK515-95A
Other languages
English (en)
Slovak (sk)
Inventor
Karin Wolter
Walter Mueller
Guenter Simon
Christa Nalbach
Rainer Hoffmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of SK51595A3 publication Critical patent/SK51595A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK515-95A 1992-10-22 1993-10-20 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline active ingredients, and processs for producing the same SK51595A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92118036A EP0593807A1 (en) 1992-10-22 1992-10-22 Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
PCT/EP1993/002899 WO1994008571A2 (de) 1992-10-22 1993-10-20 Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
SK51595A3 true SK51595A3 (en) 1997-03-05

Family

ID=8210159

Family Applications (1)

Application Number Title Priority Date Filing Date
SK515-95A SK51595A3 (en) 1992-10-22 1993-10-20 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline active ingredients, and processs for producing the same

Country Status (24)

Country Link
EP (2) EP0593807A1 (no)
JP (1) JP3731016B2 (no)
KR (1) KR100261913B1 (no)
AT (1) ATE165001T1 (no)
AU (1) AU674902B2 (no)
CA (1) CA2146645C (no)
CZ (1) CZ290122B6 (no)
DE (1) DE59308413D1 (no)
DK (1) DK0665745T3 (no)
ES (1) ES2116572T3 (no)
FI (1) FI112325B (no)
HR (1) HRP931308A2 (no)
HU (1) HU221594B (no)
IL (1) IL107360A (no)
MY (1) MY109783A (no)
NO (1) NO311404B1 (no)
NZ (1) NZ257829A (no)
PH (1) PH30790A (no)
PL (1) PL173552B1 (no)
SI (1) SI9300559A (no)
SK (1) SK51595A3 (no)
WO (1) WO1994008571A2 (no)
YU (1) YU48350B (no)
ZA (1) ZA937807B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433191A1 (de) * 1994-09-17 1996-03-21 Lohmann Therapie Syst Lts Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
AU718096C (en) * 1995-06-07 2001-11-22 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19733981A1 (de) * 1997-08-06 1999-02-11 Lohmann Therapie Syst Lts Transdermales Therapeutisches System (TTS) zur Abgabe von Wirkstoff durch die Haut an einen Organismus und Verfahren zur Applikation auf der Haut
WO1999022678A1 (en) * 1997-11-04 1999-05-14 Clear Sport Ltd. Improvements relating to adhesive devices such as strips, tapes, patches and the like, for application to the human body
WO1999047133A1 (en) 1998-03-16 1999-09-23 Somerset Pharmaceuticals, Inc. Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
DE19814083C2 (de) 1998-03-30 2002-02-07 Lohmann Therapie Syst Lts Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19826592A1 (de) * 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
WO2003039525A1 (en) 2001-11-05 2003-05-15 Krele Pharmaceuticals Llc Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
GEP20125717B (en) 2007-07-10 2012-12-25 Agile Therapeutics Inc Device for medicine direct dermal delivery
US20100087768A1 (en) 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
CA2793571C (en) 2010-04-30 2015-10-13 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds

Also Published As

Publication number Publication date
PL308292A1 (en) 1995-07-24
FI951887A0 (fi) 1995-04-20
NO951523D0 (no) 1995-04-21
CA2146645C (en) 2004-06-29
FI951887A (fi) 1995-04-20
ES2116572T3 (es) 1998-07-16
KR950703939A (ko) 1995-11-17
JP3731016B2 (ja) 2006-01-05
HUT71684A (en) 1996-01-29
PL173552B1 (pl) 1998-03-31
AU674902B2 (en) 1997-01-16
ZA937807B (en) 1994-05-16
KR100261913B1 (ko) 2000-08-01
JPH08502279A (ja) 1996-03-12
ATE165001T1 (de) 1998-05-15
CA2146645A1 (en) 1994-04-28
EP0665745A1 (de) 1995-08-09
MY109783A (en) 1997-06-30
HU9501125D0 (en) 1995-06-28
WO1994008571A2 (de) 1994-04-28
EP0665745B1 (de) 1998-04-15
PH30790A (en) 1997-10-17
AU5462794A (en) 1994-05-09
HRP931308A2 (en) 1994-12-31
NO951523L (no) 1995-04-21
EP0593807A1 (en) 1994-04-27
SI9300559A (en) 1994-06-30
IL107360A0 (en) 1994-01-25
CZ102295A3 (en) 1995-11-15
DE59308413D1 (de) 1998-05-20
YU48350B (sh) 1998-07-10
FI112325B (fi) 2003-11-28
WO1994008571A3 (de) 1994-05-26
YU67293A (sh) 1996-02-19
CZ290122B6 (cs) 2002-06-12
DK0665745T3 (da) 1999-02-08
HU221594B (hu) 2002-11-28
IL107360A (en) 1998-06-15
NZ257829A (en) 1996-11-26
NO311404B1 (no) 2001-11-26

Similar Documents

Publication Publication Date Title
SK51595A3 (en) Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline active ingredients, and processs for producing the same
US5462746A (en) Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
RU2140784C1 (ru) Содержащая эстрадиол трансдермальная терапевтическая система
US5730999A (en) Dermal therapeutic system made of a meltable poly (meth) acrylate
KR950013461B1 (ko) 피부투과성 다중합체 약제 전달 시스템
KR100300477B1 (ko) 활성성분으로서 갈란타민을 포함하는 경피치료시스템
US7993671B2 (en) Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
SK279112B6 (sk) Spôsob výroby transdermálneho terapeutického systé
US9656441B2 (en) Transdermal patch
DE3880212T2 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
SK8198A3 (en) Hormone patch
SK281623B6 (sk) Náplasť obsahujúca účinnú látku na kontrolované podávanie estradiolu a jej použitie
CZ300707B6 (cs) Transdermální terapeutický systém obsahující hormony a inhibitory krystalizace
CA2602534C (en) Transdermal patch
CZ75797A3 (en) Transdermal therapeutic system having the form of an adhesive plaster
WO2002003970A2 (de) Matrixkontrolliertes transdermales system für stabile derivate der ace-hemmer
WO2020092990A1 (en) Pharmaceutical compositions and methods of making a patch formulation for transdermal delivery
US7964213B2 (en) Patch and production method thereof
US8968774B2 (en) Preparation and composition of meloxicam transdermal drug delivery system
NZ234919A (en) Polymeric matrix or reservoir transdermal nitroglycerin patch which contains n-methyl-2-pyrrolidone and/or penetration enhancer(s); preparatory processes
SK281406B6 (sk) Plošne stabilizovaný farmaceutický prípravok na použitie na pokožku
SK22097A3 (en) Transdermal therapeutic system and a method for producing same
JPH07145061A (ja) 経皮吸収製剤
WO2015182459A1 (ja) 経皮吸収型製剤